Amphastar Pharmaceuticals Inc

-0.37 (-0.98%)
5:54:30 PM EDT: $38.30 +0.75 (+2.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.80B
Current PE19.68
Forward PE 18.59
2yr Forward PE 17.07
See more stats
Estimates Current Quarter
Revenue$133.34 Million
Adjusted EPS$0.47
See more estimates
10-Day MA$37.22
50-Day MA$33.47
200-Day MA$31.48
See more pivots

Amphastar Pharmaceuticals Inc Stock, NASDAQ:AMPH

11570 6th Street, Rancho Cucamonga, California 91730
Phone: +1.909.980.9484
Number of Employees: 1615


Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.